Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XAY.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAY.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.35ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used